COMMUNIQUÉS West-GlobeNewswire

SAFE - Chiffre d’affaires du premier semestre 2025 : 2,5 M€
31/07/2025
Chiffre d’affaires du premier semestre 2025 : 2,5 M€ En K€ S1 2025* S1 2024 Variation en % Chiffre d'affaires 2 557 2 587 -1,2% Safe Orthopaedics 1 457 1 303 11,8% Safe Medical 1 100 1 284 -14,3% * Chiffres 2025 non [...]
Availability of 2025 Half-Year Financial Report
31/07/2025
Press Release Paris – July 31, 2025 – EUROAPI posted today its 2025 condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2025. This document is available for consultation and [...]
Mise à disposition du Rapport financier semestriel 2025
31/07/2025
Communiqué de presse Paris – Le 31 juillet 2025 – EUROAPI a mis en ligne ce jour ses Etats Financiers semestriels consolidés condensés 2025 pour la période close le 30 juin 2025. Ce document est accessible et [...]
Press release: Online availability of Sanofi’s half-year financial report for 2025
31/07/2025
Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31, 2025 . Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and has been filed [...]
Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sanofi
31/07/2025
Mise en ligne du rapport financier semestriel 2025 de Sanofi Paris, le 31 juillet 2025 . Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son [...]
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
31/07/2025
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025)
31/07/2025
Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) Attachment 2025 Half-year Financial Report_Ipsen SA
Ipsen S.A. publie son Rapport financier semestriel 2025 (semestre clos le 30 juin 2025)
31/07/2025
Ipsen S.A. publie son Rapport financier semestriel 2025 (semestre clos le 30 juin 2025) Pièce jointe 2025 Rapport semestriel_Ipsen SA
Press release: Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia
31/07/2025
Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without treatment, there is a [...]
LifeMD Names COO and Promotes Two Executives
31/07/2025
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating Officer. Ms. Webb [...]
Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
31/07/2025
THE WOODLANDS, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Nasdaq’s listing qualifications staff has determined that the closing bid price of the Company’s [...]
Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance
31/07/2025
COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash consideration of USD 160 [...]
Accelerating Alzheimer’s Research: Groundbreaking Alzheimer's Disease Dataset Now Available to the Public
31/07/2025
Data from Most Deeply Characterized Cohort Across Alzheimer's Disease Released by Global Alzheimer’s Platform Foundation and Alzheimer’s Disease Data Initiative WASHINGTON, July 31, 2025 (GLOBE NEWSWIRE) -- The Global [...]
Silexion Therapeutics Announces New Preclinical Data Showing Up to 97% Inhibition of Cancer Cell Growth, Including New Evidence Against New Previously Untested KRAS Mutation
31/07/2025
New Results Reveal Unprecedented Inhibition Rates and First Evidence of SIL204's Efficacy Against Previously Untested KRAS Q61H Mutation in Human Cancer Cells, Significantly Expanding its Pan-KRAS Potential; Company on [...]
ADR Ratio Change Effective
31/07/2025
July 31, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Effective ADSs Outstanding Post Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company [...]
CoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer
31/07/2025
HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- CoRegen , a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the appointment of [...]
Elucent Medical Marks 25,000 Lives Impacted Through EnVisio® Technology
31/07/2025
MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce that more than 25,000 successful procedures have been performed using the EnVisio® In-Body Spatial Intelligence™ platform. This [...]
AIM ImmunoTech Announces Closing of $8.0 Million Public Offering
31/07/2025
OCALA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the closing of its previously announced public offering of an aggregate of 2,000,000 shares of its [...]
The Global Biologics Outsourcing Market Accounted for $20.7B in 2024 Driven by Rising Demand for Modality-Specific, End-to-End CDMO Capabilities, Finds Alira Health
31/07/2025
Annual, signature publication provides updated analysis of global CDMO trends, market shifts, and the accelerating impact of advanced therapies FRAMINGHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Alira Health, a global [...]

Pages